These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma. Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575 [TBL] [Abstract][Full Text] [Related]
65. Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study. Xu Y; Zheng Y; Sun X; Yu X; Gu J; Wu W; Zhang G; Hu J; Sun W; Mao W Oncotarget; 2015 Nov; 6(35):38429-39. PubMed ID: 26392415 [TBL] [Abstract][Full Text] [Related]
66. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045 [TBL] [Abstract][Full Text] [Related]
67. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. Foroulis CN; Thorpe JA Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389 [TBL] [Abstract][Full Text] [Related]
68. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma. Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564 [TBL] [Abstract][Full Text] [Related]
69. [Photodynamic therapy for dysphagia due to esophageal carcinoma]. Kashtan H; Konikoff F; Haddad R; Umansky M; Skornick Y; Halpern Z Harefuah; 1999 Nov; 137(10):441-4, 512. PubMed ID: 10959338 [TBL] [Abstract][Full Text] [Related]
70. Photodynamic therapy of cancer of the esophagus using systemic aminolevulinic acid and a non laser light source: a phase I/II study. Kashtan H; Konikoff F; Haddad R; Skornick Y Gastrointest Endosc; 1999 Jun; 49(6):760-4. PubMed ID: 10343224 [TBL] [Abstract][Full Text] [Related]
71. Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinoma. Ma HB; Di ZL; Wen J; Ke Y; Sun X; Ren J Jpn J Clin Oncol; 2015 Feb; 45(2):169-75. PubMed ID: 25416813 [TBL] [Abstract][Full Text] [Related]
72. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers. Otowa Y; Nakamura T; Takiguchi G; Yamamoto M; Kanaji S; Imanishi T; Oshikiri T; Suzuki S; Tanaka K; Kakeji Y Eur J Surg Oncol; 2016 Mar; 42(3):407-11. PubMed ID: 26733367 [TBL] [Abstract][Full Text] [Related]
73. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma. Taniyama Y; Nakamura T; Mitamura A; Teshima J; Katsura K; Abe S; Nakano T; Kamei T; Miyata G; Ouchi N Ann Thorac Surg; 2013 Jun; 95(6):1930-7. PubMed ID: 23642437 [TBL] [Abstract][Full Text] [Related]
74. The effect of photodynamic therapy with talaporfin sodium, a second-generation photosensitizer, on oral squamous cell carcinoma: A series of eight cases. Ikeda H; Ohba S; Egashira K; Asahina I Photodiagnosis Photodyn Ther; 2018 Mar; 21():176-180. PubMed ID: 29198764 [TBL] [Abstract][Full Text] [Related]
75. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study. Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289 [TBL] [Abstract][Full Text] [Related]
77. Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery. Lu JC; Tao H; Chen ZZ; Qian PD Dis Esophagus; 2009; 22(6):490-5. PubMed ID: 19191849 [TBL] [Abstract][Full Text] [Related]
78. Texture and color enhancement imaging improve visibility in photodynamic therapy for patients with esophageal squamous cell carcinoma. Nakamura J; Hikichi T; Hashimoto M Dig Endosc; 2024 Jun; 36(6):744-746. PubMed ID: 38600629 [No Abstract] [Full Text] [Related]
79. Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. Copper MP; Tan IB; Oppelaar H; Ruevekamp MC; Stewart FA Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):709-11. PubMed ID: 12874068 [TBL] [Abstract][Full Text] [Related]
80. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma. Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]